Banks M - Search Results

1

Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation.

Graber P, Proudfoot AE, Talabot F, Bernard A, McKinnon M, Banks M, Fattah D, Solari R, Peitsch MC, Wells TN. Graber P, et al. Among authors: banks m. J Biol Chem. 1995 Jun 30;270(26):15762-9. doi: 10.1074/jbc.270.26.15762. J Biol Chem. 1995. PMID: 7797578 Free article.

2

Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants.

Banks M, Graber P, Proudfoot AE, Arod CY, Allet B, Bernard AR, Sebille E, McKinnon M, Wells TN, Solari R. Banks M, et al. Anal Biochem. 1995 Sep 20;230(2):321-8. doi: 10.1006/abio.1995.1481. Anal Biochem. 1995. PMID: 7503425

3

The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization.

Proudfoot AE, Brown SC, Graber P, Talabot F, Arod CY, Peitsch MC, Banks M, McKinnon M, Solari R, Wells TN. Proudfoot AE, et al. Among authors: banks m. J Protein Chem. 1996 Jul;15(5):491-9. doi: 10.1007/BF01886857. J Protein Chem. 1996. PMID: 8895095

4

Defining the regions of human interleukin-5 important in receptor binding and cellular activation.

Wells TN, Graber P, McKinnon M, Banks M, Fattah D, Solari R, Peitsch MC, Proudfoot AE. Wells TN, et al. Among authors: banks m. Ann N Y Acad Sci. 1996 Oct 31;796:226-34. doi: 10.1111/j.1749-6632.1996.tb32585.x. Ann N Y Acad Sci. 1996. PMID: 8906230 No abstract available.

5

An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.

McKinnon M, Page K, Uings IJ, Banks M, Fattah D, Proudfoot AE, Graber P, Arod C, Fish R, Wells TN, Solari R. McKinnon M, et al. Among authors: banks m. J Exp Med. 1997 Jul 7;186(1):121-9. doi: 10.1084/jem.186.1.121. J Exp Med. 1997. PMID: 9207003 Free PMC article.

6

Marine organisms in somatostatin receptor scintillation proximity assays.

Mills K, Stead P, Banks M. Mills K, et al. Among authors: banks m. Biochem Soc Trans. 1997 Nov;25(4):S636. doi: 10.1042/bst025s636. Biochem Soc Trans. 1997. PMID: 9450064 No abstract available.

7

Identification of a potent and selective oxytocin antagonist, from screening a fully encoded differential release combinatorial chemical library.

Evans B, Pipe A, Clark L, Banks M. Evans B, et al. Among authors: banks m. Bioorg Med Chem Lett. 2001 May 21;11(10):1297-300. doi: 10.1016/s0960-894x(01)00201-3. Bioorg Med Chem Lett. 2001. PMID: 11392541

8

The chemical-biological interface: developments in automated and miniaturised screening technology.

Houston JG, Banks M. Houston JG, et al. Among authors: banks m. Curr Opin Biotechnol. 1997 Dec;8(6):734-40. doi: 10.1016/s0958-1669(97)80128-0. Curr Opin Biotechnol. 1997. PMID: 9425665 Review.

9

Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the δ-opioid receptor.

Burford NT, Livingston KE, Canals M, Ryan MR, Budenholzer LM, Han Y, Shang Y, Herbst JJ, O'Connell J, Banks M, Zhang L, Filizola M, Bassoni DL, Wehrman TS, Christopoulos A, Traynor JR, Gerritz SW, Alt A. Burford NT, et al. Among authors: banks m. J Med Chem. 2015 May 28;58(10):4220-9. doi: 10.1021/acs.jmedchem.5b00007. Epub 2015 May 7. J Med Chem. 2015. PMID: 25901762 Free PMC article.

10

Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.

Houston JG, Banks MN, Binnie A, Brenner S, O'Connell J, Petrillo EW. Houston JG, et al. Drug Discov Today. 2008 Jan;13(1-2):44-51. doi: 10.1016/j.drudis.2007.11.004. Epub 2008 Jan 3. Drug Discov Today. 2008. PMID: 18190863 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,003 results

Search Page

Filters